As a step in elucidating the biological role of plasma kallikrein (PK) present in the follicular fluid of mammalian ovaries, we examined pig ovary fluid to determine its constituent activators and substrates. Using the inactive precursor form of plasma kallikrein (prePK) as a substrate, we purified an enzyme capable of activating this protein. The prePK-activating enzyme was shown to be the active enzyme blood coagulation factor XIIa. We also isolated high molecular weight kininogen (HMW-K) from the same fluid. Incubation of HMW-K with the ovarian follicular fluid PK resulted in the production of the nanopeptide bradykinin (BK). Expression of prePK, blood coagulation factor XII, and HMW-K was examined by Northern blot analysis using ovary and liver poly(A) ؉ RNA. All these transcripts were found in the liver, but none were found in the ovary. In addition, it was found that BK levels in the fluid derived from the small follicles were approximately 6 times higher than those from medium and large follicles. These results demonstrate the presence of a BK-producing system in the ovarian follicles and suggest the physiological importance of this peptide hormone in the early stages of follicular development and at ovulation.
INTRODUCTION
The germ cells in the ovaries grow to maturity in individual follicles and are eventually liberated under hormonal controls. The accumulation of fluid in the follicular space is a characteristic feature of mature ovarian follicles in most mammals. The follicular fluid contains a variety of proteins whose origin is generally thought to be either the plasma or the follicle itself [1] . The occurrence of several proteolytic enzymes in the fluid has been documented [2] [3] [4] [5] [6] .
We previously reported that the follicular fluid of porcine ovaries contains the serine proteinase follipsin [7, 8] . Our subsequent studies revealed that plasma kallikrein (PK) is structurally and functionally homologous to porcine follipsin [9, 10] . These findings prompted us to further investigate the biological significance of the presence of intrafollicular PK using porcine ovaries. In the study reported here, we demonstrated that the follicular fluid contains factor XIIa as an activator of PK and high molecular weight kininogen (HMW-K) as a substrate of PK. The current study also showed a significant change in the intrafollicular con- These results strongly suggest that the BK-generating system plays an important role in the development of ovarian follicles as well as at ovulation.
MATERIALS AND METHODS

Materials
Two synthetic substrates, butyloxycarbonyl(Boc)-GlnArg-Arg-4-methylcoumaryl-7-amide (MCA) for prePK (inactive precursor form of plasma kallikrein)-activating enzyme and benzoyl-Arg-MCA for papain-inhibiting activity of HMW-K, were purchased from the Peptide Institute (Osaka, Japan). DE-52 and CM-52 were obtained from Whatman (Clifton, NJ). Benzamidine-Sepharose 6B was purchased from Amersham Pharmacia Biotech Inc. (Piscataway, NJ). An SG-120 C-12 reversed-phase HPLC column was obtained from Shiseido (Tokyo, Japan). Rabbit anti-human factor XII antiserum and rabbit anti-human HMW-K antiserum were purchased from Nordic Immunological Laboratories, Ltd. (Amsterdam, Netherlands) and The Binding Site, Ltd. (Birmingham, UK), respectively. Other reagents were obtained from the indicated sources.
Preparation of Porcine Follicular Fluid
Porcine ovaries were obtained from a local slaughterhouse within 30 min of the animals' deaths and were transferred to the laboratory on ice. Follicular contents were aspirated from porcine ovarian follicles with a syringe and a 26-gauge needle, and were centrifuged at 1000 ϫ g for 20 min at 4ЊC to remove oocytes, granulosa cells, and debris. The resulting supernatant was further centrifuged at 10 000 ϫ g for 20 min at 4ЊC to obtain a clear supernatant.
In some experiments, small (1-3 mm in diameter), medium (4-6 mm), and large (6-8 mm) follicles of porcine ovaries were aspirated. Criteria for sizing the follicles were based on those of Akins and Morrissette [11] .
Enzyme Assay
Enzyme activity of ovarian follicular fluid prePK-activating enzyme was assayed as previously described [10] . Briefly, aliquots of the fractions were incubated at 37ЊC in a volume of 32 l in 0.1 M Tris-HCl (pH 8.0) with 5.6 pmol prePK for 5 min. The enzyme activities of the activated PK were then assayed with Boc-Gln-Arg-Arg-MCA. The release of fluorophore, 7-amino-4-methylcoumarin, was measured by spectrofluorometry using an excitation wavelength of 370 nm and an emission wavelength of 460 nm. Net activity was obtained by subtracting the appropriate control values. HMW-K was assayed for its inhibitory activity toward the cysteine protease papain [12] using benzoyl-Arg-MCA.
Purification of PrePK-Activating Enzyme
The follicular fluid of porcine ovaries (50 ml) was dialyzed against 50 mM sodium acetate (pH 6.0). After removing insoluble materials by centrifugation, the clear supernatant was applied to a CM-52 column (2.4 ϫ 25 cm) previously equilibrated with 50 mM sodium acetate (pH 6.0). The column was washed extensively and eluted with a linear gradient of NaCl using 300 ml each of 50 mM sodium acetate (pH 6.0) and the same buffer containing 0.2 M NaCl. The active fractions (a total of 60 ml) were collected, pooled, dialyzed against 20 mM Tris-HCl (pH 7.4), and applied to a DE-52 column (0.8 ϫ 3.8 cm) previously equilibrated with 20 mM Tris-HCl (pH 7.4). The retained proteins were eluted with a linear gradient of NaCl using 20 ml each of 20 mM Tris-HCl (pH 7.4) and the same buffer containing 0.4 M NaCl. The active fractions (a total of 11 ml) were collected, pooled, and applied directly to a benzamidine-Sepharose 6B column (0.8 ϫ 1.9 cm) previously equilibrated with 20 mM Tris-HCl (pH 7.4) containing 0.2 M NaCl. The retained proteins were eluted with the buffer containing 50 mM benzamidine. The enzyme activity was assayed using Boc-Gln-Arg-Arg-MCA as substrate as described above. Fractions were monitored for protein at 300 nm in CM-52 column chromatography because the concentrations were too high to determine at 280 nm, while fractions from DE-52 and benzamidine-Sepharose 6B columns were monitored at 280 nm.
Purification of HMW-K
HMW-K was purified from the follicular fluid of porcine ovaries by a modification of the method described previously for the purification of plasma HMW-K [13] . Follicular fluid (50 ml) was diluted 6 times with 121 mM Trissuccinic acid buffer (pH 7.7) containing EDTA (1 mM), benzamidine (1 mM), ⑀-aminocaproic acid (1 mM), polybrene (50 g/ml), and NaN 3 (0.02%), and applied to a DE-52 column (2.4 ϫ 20 cm). The column was eluted with 193 mM Tris-succinic acid buffer (pH 7.4) containing benzamidine (1 mM), ⑀-aminocaproic acid (1 mM), polybrene (50 g/mL), and NaN 3 (0.02%). The fractions (a total of 50 ml) having papain-inhibiting activity (determined using benzoyl-Arg-MCA as substrate) were collected, pooled, and applied directly to a zinc-chelate Cellulofine column (1.8 ϫ 8 cm; Seikagaku Corp., Tokyo, Japan) equilibrated with 25 mM Tris-HCl (pH 8.0) containing benzamidine (1 mM), ⑀-aminocaproic acid (1 mM), histidine (20 mM), NaCl (0.2 M), and NaN 3 (0.01%). After unretained materials were removed by washing with the above buffer, the column was eluted with 25 mM Tris-HCl (pH 8.0) containing benzamidine (1 mM), ⑀-aminocaproic acid (1 mM), histidine (20 mM), NaCl (0.2 M), NaN 3 (0.01%), and 5 mM EDTA. Fractions were monitored for protein at 300 nm in DE-52 column chromatography because the concentrations were too high to determine at 280 nm, while fractions from the zinc-chelate Cellulofine column were monitored at 280 nm.
Electrophoresis and Western Blot Analysis
SDS-PAGE was performed using a 10% acrylamide gel according to the method of Laemmli [14] and was followed by silver staining. Proteins separated by SDS-PAGE were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore Corp., Bedford, MA) using Towbin's transfer buffer [15] . The blotted membranes were treated with Block Ace (Dainippon Seiyaku, Tokyo, Japan) at room temperature for 1 h. The membranes were incubated with primary antibodies at a 1:2000 dilution and subsequently with appropriate biotinylated, secondary antibodies. The membrane was then incubated with streptavidin conjugated with horseradish peroxidase, and immunoreactive signals on the membrane were detected by means of an ECL Western blot detection kit (Amersham Pharmacia Biotech).
Amino Acid Sequence Analysis
Polypeptides separated by SDS-PAGE were electroblotted onto a PVDF membrane and analyzed for NH 2 -terminal amino acid sequences in a PE Applied Biosystems (Foster City, CA) model 477A sequenator [16] .
cDNA Cloning of PrePK-Activating Enzyme
Total RNA was obtained from porcine liver using ISO-GEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. Poly(A) ϩ RNA was isolated by oligo(dT)-cellulose column chromatography. A cDNA library was constructed in gt10 vector (Takara, Tokyo, Japan) using Gigapack III Gold packaging Extract (Stratagene, La Jolla, CA). The library was screened using a 1001-base pair (bp) digoxigenin-labeled reverse transcription (RT)-polymerase chain reaction (PCR) product, which had been prepared by amplifying with porcine liver mRNA using a sense primer of 5Ј-CCGGGGARCCCTGCCACTTC-3Ј corresponding to nucleotides 97-116 and an antisense primer of 5Ј-GCGGCGATGTAGGGGTGCGC-3Ј corresponding to nucleotides 1097-1078 of bovine factor XII [17] . From the 4.5 ϫ 10 5 plaques screened, 4 positives were obtained and subjected to sequence analysis. The longest cDNA clone thus obtained had an insert of 2027 bp that still lacked several nucleotides at the 5Ј-end region of the coding sequence.
To isolate the 5Ј-end region of factor XII mRNA, a 5Ј-rapid amplification of mRNA ends (5Ј-RACE) [18] was performed using a 5Ј-Full RACE Core Set (Takara) according to procedures recommended by the manufacturer. Briefly, cDNA was synthesized by priming with 5Ј-end phosphorylated 14-mer nucleotides (5Ј-TCAGAGAAGA-CAGC-3Ј corresponding to nucleotides 1108-1095 of porcine factor XII) using poly(A) ϩ RNA isolated from the liver. The first PCR amplification was performed using a sense primer of 5Ј-CTCAAGGAGAGGTGCTACAG-3Ј (corresponding to nucleotides 637-656) and an antisense primer of 5Ј-CTTATGCTTCCTGGGGTCT-3Ј (corresponding to nucleotides 90-72). The second PCR amplification was performed with a sense primer of 5Ј-GCCACCTA-CTGGAACATGAC-3Ј (corresponding to nucleotides 733-752) and an antisense primer of 5Ј-GTGGAATCAAAA-GAGCTGACTC-3Ј (corresponding to nucleotides 64-43). The final PCR product was cloned into the pBluescript II phagemid and sequenced.
Nucleotide Sequence Analysis
DNA sequencing was performed using either a PE Applied Biosystems 373A or 377A DNA sequencer.
Northern Blot Analysis
The Northern blot techniques used were basically as described by Sambrook et al. [19] . Five-microgram portions of poly(A) ϩ RNA isolated from whole porcine ovary and liver were electrophoresed in a 1.2% agarose gel and trans- Flow rate, 43 ml/h; fraction size, 10 ml; monitoring absorbance, 300 nm. B) Chromatography on a DE-52 column. Flow rate, 40 ml/h; fraction size, 1 ml; monitoring absorbance, 280 nm. C) Chromatography on a benzamidine-Sepharose 6B column. Flow rate, 24 ml/h; fraction size, 1 ml; monitoring absorbance, 280 nm. A horizontal bar indicates the fractions pooled.
FIG. 2. Electrophoretic analysis of prePK-activating enzyme.
A) SDS-PAGE analysis. The enzyme (1 g protein) was electrophoresed on a 10% polyacrylamide gel in the presence of SDS under reducing (left lane) and nonreducing (right lane) conditions, and the separated polypeptides were silver-stained. The relative molecular masses (kDa) of the polypeptides are shown. B) Western blot analysis. The blotted polypeptides were analyzed using anti-human factor XII antiserum. The 42-kDa band indicated by an arrow is presumably an impurity. ␤ME, ␤-mercaptoethanol. To this end, the PCR was conducted using total porcine liver RNA with a sense primer of 5Ј-GTACAAGATGAAGA-GCGGGA-3Ј corresponding to nucleotides 1310-1329 and an antisense primer of 5Ј-TTTGGGGGAGGTTGTTTCTG-3Ј corresponding to nucleotides 1849-1830 of bovine HMW-K [20] . The product was confirmed to be a fragment of porcine HMW-K DNA by nucleotide sequencing. The blotted membrane was hybridized with [␣ 32 P]dCTP random-labeled probes at 42ЊC in 50% formamide, 5-strength Denhardt's solution, 5-strength SSPE (single-strength SSPE is 150 mM NaCl, 10 mM NaH 2 PO 4 , 1 mM Na/EDTA), 1% SDS, and 100 g/ml herring sperm DNA, and was washed twice in double-strength SSC (single-strength SSC is 0.15 M sodium chloride, 0.015 M sodium citrate)/0.05% SDS at 50ЊC, and once each in single-strength SSC/0.1% SDS and double-strength SSC at the same temperature.
HPLC Analysis of BK
The HMW-K sample (0.6 nmol) purified from the follicular fluid of porcine ovaries as described above was in- cubated at 37ЊC with ovarian PK (27 pmol) in 200 l of 0.1 M Tris-HCl (pH 8.0) for 5 min. Incubation was terminated by adding trifluoroacetic acid at a final concentration of 0.1%. The samples were passed through a 0.4-m filter, and 175-l aliquots were applied to a reversed-phase HPLC column equilibrated with 0.1% trifluoroacetic acid. The column was then eluted with a linear gradient (0-70%) of acetonitrile containing 0.1% trifluoroacetic acid, and absorbance was monitored at 220 nm. The peak was collected for amino acid sequence analysis.
Quantification of Follicular Fluid BK
Follicular fluids aspirated from small, medium, and large follicles were immediately mixed with 4 volumes of icecold ethanol, and the mixtures were centrifuged to recover the supernatants. The precipitates were again extracted with 80% ethanol. The supernatants thus obtained were combined and evaporated to dryness. After the pellets were dissolved in a small volume of distilled water, the solutions were adjusted to pH 2 using 0.1 N HCl. These solutions were washed twice with 3 volumes of diethyl ether, and the aqueous phases were dried. The resulting pellets were dissolved in distilled water for the determination of BK. The quantities of BK and (1-5)-BK (Arg-Pro-Pro-Gly-Phe) in the samples prepared above were estimated by ELISA using Markit-M BK and Markit-M (1-5)-BK kits (Dainippon Seiyaku, Tokyo, Japan), respectively. BK and (1-5)-BK in plasma were also determined by the same procedure.
RESULTS
Structural Characterization of Ovarian Follicular Fluid PrePK-Activating Enzyme
We confirmed our previous observation [10, 21] that the ovarian follicular fluid contains an enzyme capable of activating prePK. In order to determine its chemical makeup, we purified the enzyme by a series of column chromatographic steps on CM-52, DE-52, and benzamidine-Sepharose 6B columns (Fig. 1) . The purified enzyme showed two bands of 89 kDa and 84 kDa under nonreducing conditions in SDS-PAGE. In contrast, SDS-PAGE of the enzyme under reducing conditions gave a clear band at a position of 39 kDa and broad bands at around 52 kDa (Fig. 2A) . The NH 2 -terminal amino acid sequence analysis of the 39-kDa polypeptide produced a single sequence of Ile-Val-Gly-GlyLeu-Val-Ala-Leu-Pro-Gly-Ala-His-Pro-Tyr-Ile-Ala-AlaLeu (18 amino acid residues). The sequence was found to be the same as the NH 2 -terminal amino acid sequence of the catalytic domain of guinea pig factor XIIa [22] and was highly homologous to those of the domain of bovine [17] , human [23, 24] , and mouse factor XIIa (DDBJ accession number X99571). These results strongly suggest that the activating enzyme is factor XIIa. Consistent with this idea, the 89-, 84-, and 39-kDa polypeptides separated in SDS-PAGE were indeed recognized with anti-human factor XIIa antibody as examined by Western blot analysis (Fig. 2B) . To further characterize the enzyme structurally, we conducted cDNA cloning experiments. Using a 1-kb porcine factor XII cDNA fragment corresponding to nucleotides 97-1097 of the bovine cDNA [17] , we isolated 4 clones from the liver cDNA library. From analysis of these clones and the results of 5Ј-RACE experiments, we established the nucleotide sequence of porcine factor XII (the nucleotide FIG. 6 . BK liberation from the follicular fluid HMW-K by porcine ovarian PK. The HMW-K sample incubated with porcine PK was analyzed on a reversed-phase HPLC column in a 0.1% trifluoroacetic acid/acetonitrile system. The peak eluted at 16 min (indicated by an arrow) was collected and analyzed for its amino acid sequence. A) HMW-K was incubated alone; B) PK was incubated alone; C) HMW-K was incubated with PK.
FIG. 7. Northern blot analysis of mRNA isolated from porcine ovary and liver. Poly(A)
ϩ RNAs were prepared from pig ovary and liver. A 5-g portion of poly(A) ϩ RNAs from the tissues was analyzed for mRNAs of PK (A), factor XII (B), and HMW-K (C) by hybridization with the respective porcine cDNA fragments (see Materials and Methods).
sequence is available from the DDBJ/EMBL/GenBank Data Bank under accession No. AB022426). It encodes a predicted protein of 643 amino acids having a putative signal peptide of 14 amino acid residues. As a whole, the amino acid sequence has 80.9% identity with that of bovine factor XII. It also shows a high degree of homology with human (71.9% identity) [23, 24] , guinea pig (70.5% identity) [22] , and mouse factor XII (67.9% identity; cited from DDBJ data base accession No. X99571). The NH 2 -terminal 18-amino acid residue sequence of the 39-kDa polypeptide described above perfectly corresponds to the residues Ile 372 to Leu 389 in the deduced sequence.
The NH 2 -terminal amino acid sequences of the 89-kDa and 84-kDa polypeptides, which were separated in SDS-PAGE under nonreducing conditions, were also determined by Edman degradation. Both polypeptides contained two sets of sequences. The 89-kDa polypeptide produced Ile/ Val-Met/Val-Ala/Gly-Ser/Gly-Leu/Glu-, while the 84-kDa polypeptide produced Ile/Trp-Val/Ala-Gly/Tyr-Gly-Leu-. The results indicate that both the 89-kDa and 84-kDa polypeptides commonly contain an NH 2 -terminal amino acid sequence of Ile-Val-Gly-Gly-Leu-, a sequence corresponding to the first 5 residues of the 39-kDa polypeptide. Additional sequences existing in the 89-kDa and 84-kDa polypeptides were presumed to be Val-Met-Ala-Ser-Glu-and Trp-Ala-Tyr-X-Leu-, respectively. On the basis of these results, it is reasonable to conclude that factor XIIa purified from the follicular fluid of porcine ovary is a two-chain enzyme. The enzyme exists in two different forms with a common COOH-terminal catalytic domain starting at Ile 383 . The two forms of the enzyme differ only in their NH 2 -terminal domain. The NH 2 terminus of the polypeptides is either Val 29 or Trp 83 (Fig. 3) . The 52-kDa and 46-kDa polypeptides separated in SDS-PAGE ( Fig. 2A) are most likely the NH 2 -terminal domains of the two isoforms, although an NH 2 -terminal amino acid sequence analysis of the polypeptides was not conducted. The reason why these polypeptides were not visible in Western blot analysis (Fig. 2B) is probably that the anti-human factor XIIa antibody used in this experiment poorly recognizes the NH 2 -terminal domain of porcine factor XIIa.
HMW-K from Porcine Ovarian Follicular Fluid
After identifying PK and factor XIIa in the follicular fluid, we attempted to determine whether HMW-K, a physiological substrate of PK, coexists in the same fluid. A preliminary Western blot experiment using anti-human HMW-K antibody strongly suggested that the fluid indeed contained proteins cross-reactive with the antibody. Therefore, we attempted to purify the proteins from the follicular fluid of porcine ovaries by a combination of column chromatographies on DE-52 and zinc-chelate Cellulofine (Fig. 4) . The results of the SDS-PAGE analysis of the purified protein are shown in Figure 5 . The 140-kDa and 105-kDa polypeptides were separated on SDS-PAGE under nonreducing conditions. Similar results were reported for HMW-K purified from porcine plasma, except that the apparent molecular mass of the larger polypeptide was 200 kDa [13] . These polypeptides (140 kDa and 105 kDa) are presumed to be dimeric and monomeric forms of HMW-K, respectively [25] . As shown in Figure 5B , anti-human HMW-K antibody recognized the 120-kDa polypeptide (reducing) as well as the 140-kDa and 105-kDa polypeptides (nonreducing). The 60-kDa polypeptide stained in SDS-PAGE under reducing conditions was judged to be an impurity, since the polypeptide was not recognized by the antibody. To further identify the purified protein as HMW-K, its reactivity to PK was examined. Incubation with PK produced a single HPLC peak at an elution time of 16 min (Fig. 6) . The amino acid sequence of the peak was found to be Arg-ProPro-Gly-Phe-Ser-Pro-Phe-Arg, which is the same as that of human BK [26] . The electrophoretic data indicated that the purified sample contained virtually no nicked or kinin-free HMW-K.
It must be noted that the flow-through fractions of DE-52 column chromatography (Fig. 4A ) exhibited a significant papain-inhibiting activity (data not shown), indicating the presence of another type of kininogen in the follicular fluid. However, this fraction was found not to be retained on the zinc-chelate Cellulofine column. These results strongly suggest that the fluid also contains low-molecular weight kininogen (LMW-K).
mRNA Detection of the Components of the BK-Producing System
The above results clearly indicate that the BK-producing system is present in the follicles of porcine ovary. We next examined whether the components are expressed in the ovary. A Northern blot analysis was performed with 32 Plabeled respective porcine cDNA fragments using total RNA of the porcine ovary and liver. Transcripts of 2.40 kb (PK), 2.05 kb (factor XII), and 3.05 kb (HMW-K) were not found in the ovary, whereas a significant expression of the transcripts was observed with the liver total RNA (Fig. 7) .
BK Concentration in the Fluid
The amounts of BK and of the degraded product (1-5)-BK were determined using follicular fluids derived from various sizes of porcine ovarian follicles. As shown in Figure 8 , BK levels were 6 times higher in the fluid derived from small follicles than in fluids from medium and large follicles. The plasma levels of this peptide were comparable to its intrafollicular levels in the medium-and large-sized follicles. Similarly, the (1-5)-BK levels were the greatest in the small follicles; these levels drastically decreased as the follicles grew. This degradation product was present in the plasma at a significantly higher level than in the fluids of the medium-and large-sized follicles.
DISCUSSION
Previous studies have demonstrated an increase in ovarian kinin-producing activity during ovulation [27] [28] [29] . Moreover, it has been established that BK induces ovulation in perfused rabbit ovaries [30] [31] [32] and potentiates the action of LH [33] . Despite the fact that the role of BK in mammalian ovaries is well recognized, little is known about how the peptide hormone is produced in vivo. As a first step in approaching this problem, we investigated whether the components responsible for the production of BK are present in individual ovarian follicles. The current results indicate that the follicular fluid of porcine ovary contains factor XIIa as an activator of the inactive precursor PK as well as HMW-K as a substrate of PK. To the best of our knowledge, this is the first biochemical demonstration of the presence of an intrafollicular BK-producing system in the ovary. Our present finding that not only the components for a BK-producing system, but also the product BK, exist in the follicular fluid of the porcine ovary strongly suggests that BK can be produced within ovarian follicles. However, its production in the follicles still remains to be demonstrated.
In this study, the presence of LMW-K in the follicular fluid of the porcine ovary was implied. This points to the possibility that intrafollicular kallidin (lysyl-BK) might also be produced from LMW-K. A tissue kallikrein is generally thought to catalyze the production of kinin from LMW-K. Several investigators have indeed reported an increase in tissue kallikrein activity [27] [28] [29] 34 ] with a concomitant elevation of LMW-K [28] in rat ovary extract during ovulation. At present, however, it is not known to what extent the LMW-K/tissue kallikrein system contributes to kinin formation within porcine ovarian follicles.
Upon Northern blot analysis of the total RNA fraction prepared from porcine ovary, no clear transcript was detected for any components of the BK-producing system. On the other hand, the total RNA fraction from the liver gave detectable signals for all of the components.
These observations, together with the generally accepted idea that prePK, HMW-K, and factor XII in the plasma are synthesized in and secreted from the liver cells, might lead to the conclusion that the components constituting the intrafollicular BK-producing system are of hepatic origin. If this were the case, an unknown mechanism would be responsible for moving such compounds into the follicles from the circulatory system surrounding them. Alternatively, it may be that these protein components for the intrafollicular BK-producing system are synthesized within the follicle itself, but that Northern blot analysis is not sensitive enough to detect the respective transcripts. Since poly(A) ϩ RNAs were extracted from a whole ovary, transcripts of the components, which may be expressed specifically in follicle cells in low abundance, may have been diluted out during the analysis. At any rate, the derivation of the intrafollicular components of the system is not clear at present. Clearly, further investigations will be needed to determine the site of synthesis.
From the results shown in Figure 8A , the average intrafollicular BK concentrations were calculated to be approximately 1.4 ϫ 10 Ϫ11 , 2.8 ϫ 10 Ϫ12 , and 2.1 ϫ 10 Ϫ12 M for small, medium, and large follicles, respectively, assuming that the molecular weight of BK is 1060. In this context, it is interesting to note that the reported K d values of BK receptors for the ligand are 10 Ϫ10 -ϳ10 Ϫ8 M [35] . These considerations suggest that the BK concentration in the fluid, particularly in small growing follicles, could be within a physiological range. Follicular growth in the mammalian ovary is accompanied by a striking accumulation of fluid within the follicles that mainly originates from plasma. Because BK causes both a dilation of blood vessels and increases in vascular permeability, one possible explanation for the involvement of the peptide hormone is that its intrafollicular production would result in an increased permeability of the capillaries of small growing follicles, which in turn would enhance the transfer of plasma substances into the surrounding extravascular spaces and also into the follicular antrum. It should be noted, however, that enlargement of follicles due to increased permeability is observed throughout follicular development and is particularly pronounced in the later stages. The present finding that follicular BK levels in the follicles decreased with the growth of follicles would appear to be inconsistent with the above hypothesis, indicating the presence of a more complex mechanism(s) for follicular growth. Our results also suggest that small follicles are able to sequester BK. BK is known to be degraded rapidly in vivo, with a half-life of about 16 sec [36] . Although enzymes responsible for its degradation within the follicles are not known at present, the elevated BK level in small follicles may be due to increased activities of the BK-generating enzymes and/or decreased activities of putative BK-degrading enzymes, as compared with those in medium and large follicles.
Our present finding that BK is concentrated more in the fluid of small follicles than in the fluid of larger follicles also tempts us to speculate that this peptide hormone may play a role in the atresia of follicles, since small follicles in the antral stages are more often destined for programmed cell death by atresia than are large preovulatory follicles [37, 38] . Therefore, it would be very interesting to examine whether BK is involved in the selection and atresia of ovarian follicles.
Hellberg et al. [32] observed that BK potentiates the ovulatory response to LH in in vitro-perfused rat ovaries. In addition, BK treatment resulted in increased ovarian tissue levels of prostaglandin E 2 and prostacyclin. On the basis of these results, they proposed that vasodilatory mediators, such as prostacyclin, may potentiate vascular leakage without macromolecular permeability. To examine whether this is indeed an in vivo mechanism, it will be necessary to determine the BK concentration in graafian follicles that are about to ovulate, for which the highest BK levels are expected. The ovarian follicles used in this study were exclusively in the preovulatory stages of follicular development, and no ovulating follicles were available. Therefore, an in vitro experiment using the whole isolated follicles treated with LH will be needed to confirm the above hypothesis.
In conclusion, this study demonstrated the presence of components of the BK-producing system as well as the product BK in the ovarian follicles, suggesting important roles of BK not only in the early stages of follicular development but also at ovulation.
